These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1648882)

  • 1. Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation.
    Bogden AE; Carde P; de Paillette ED; Moreau JP; Tubiana M; Frindel E
    Ann N Y Acad Sci; 1991; 628():126-39. PubMed ID: 1648882
    [No Abstract]   [Full Text] [Related]  

  • 2. The tetrapeptide AcSDKP reduces the sensitivity of murine CFU-MK and CFU-GM progenitors to aracytine in vitro and in vivo.
    Aidoudi S; Guigon M; Drouet V; Caen JP; Han ZC
    Int J Hematol; 1998 Aug; 68(2):145-55. PubMed ID: 9803673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hematopoietic stem cell proliferation by hemoregulatory peptide pyroGlu-Glu-Asp-Cys-Lys (pEEDCK) provides protection against short-term neutropenia and long-term damage.
    Paukovits WR; Moser MH; Rutter R; Paukovits JB
    Ann N Y Acad Sci; 1991; 628():92-104. PubMed ID: 2069326
    [No Abstract]   [Full Text] [Related]  

  • 4. Response of human lung tumor xenografts to treatment with a somatostatin analogue (Somatuline).
    Bogden AE; Taylor JE; Moreau JP; Coy DH; LePage DJ
    Cancer Res; 1990 Jul; 50(14):4360-5. PubMed ID: 1973071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
    Jackson JD; Yan Y; Ewel C; Talmadge JE
    Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiproliferative activity of the tetrapeptide Acetyl-N-SerAspLysPro, an inhibitor of haematopoietic stem cell proliferation, is not mediated by a thymosin beta 4-like effect on actin assembly.
    Cheviron N; Grillon C; Carlier MF; Wdzieczak-Bakala J
    Cell Prolif; 1996 Aug; 29(8):437-46. PubMed ID: 8918557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinopril.
    Chisi JE; Wdzieczak-Bakala J; Riches AC
    Stem Cells; 1997; 15(6):455-60. PubMed ID: 9402658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
    Naoe Y; Inami M; Matsumoto S; Takagaki S; Fujiwara T; Yamazaki S; Kawamura I; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
    Jpn J Cancer Res; 1998 Dec; 89(12):1306-17. PubMed ID: 10081492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of acetyl-Ser-Asp-Lys-Pro (AcSDKP) on human hematopoietic progenitor cells in short-term and long-term bone marrow cultures.
    Jackson JD; Ozerol E; Yan Y; Ewel C; Talmadge JE
    J Hematother Stem Cell Res; 2000 Aug; 9(4):489-96. PubMed ID: 10982247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of human non-small cell lung cancer xenografts to cyclophosphamide and cisplatin.
    Mattern J; Wayss K; Volm M
    In Vivo; 1987; 1(1):23-6. PubMed ID: 2856516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem-cell survival and tumor control in the Lewis lung carcinoma.
    Steel GG; Adams K
    Cancer Res; 1975 Jun; 35(6):1530-5. PubMed ID: 1169108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catabolism of the tetrapeptide N-Ac-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of hematopoietic stem cell (CFU-S) proliferation, following in vitro incubation with hematopoietic tissues from normal and leukemic mice.
    Wdzieczak-Bakala J; Grillon C; Robinson S; Riches A; Carde P; Lenfant M
    Bull Cancer; 1993 May; 80(5):391-6. PubMed ID: 8173192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK; Konings AW
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts.
    Kudoh S; Takada M; Masuda N; Nakagawa K; Itoh K; Kusunoki Y; Negoro S; Matsui K; Takifuji N; Morino H
    Jpn J Cancer Res; 1993 Feb; 84(2):203-7. PubMed ID: 8385085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human placental low molecular weight factors inhibit the entry into cell cycle of murine pluripotent stem cells.
    Lopez M; Wdzieczak-Bakala J; Pradelles P; Frindel E
    Leukemia; 1991 Mar; 5(3):270-2. PubMed ID: 2013983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of the transplanted KHT fibrosarcoma in mice.
    Lin H; Bruce WR
    Ser Haematol; 1972; 5(2):89-104. PubMed ID: 5056789
    [No Abstract]   [Full Text] [Related]  

  • 17. The mechanism of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation.
    Robinson S; Lenfant M; Wdzieczak-Bakala J; Melville J; Riches A
    Cell Prolif; 1992 Nov; 25(6):623-32. PubMed ID: 1457609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activities of tetrapeptide AcSDKP on hemopoietic cell binding to the stromal cell in vitro.
    Aizawa S; Toyama K; Mori KJ; Frindel E
    Exp Hematol; 1992 Aug; 20(7):896-9. PubMed ID: 1628708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies].
    Carde P; Chastang C; Goncalves E; Mathieu-Tubiana N; Vuillemin E; Delwail V; Corbion O; Vekhoff A; Isnard F; Ferrero JM
    C R Acad Sci III; 1992; 315(13):545-50. PubMed ID: 1300237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
    Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.